Platelet-rich plasma for the treatment of patellar tendinopathy: clinical and imaging findings at medium-term follow-up
- 709 Downloads
The purpose of this study was to evaluate the efficacy of multiple platelet-rich plasma (PRP) injections on the healing of chronic refractory patellar tendinopathy, and report the quality and duration of the clinical improvement up to a medium-term follow-up.
Forty-three patients (mean age, 30.6 years; mean BMI, 24.7; 42 men, one woman) affected by chronic patellar proximal tendinopathy were enrolled in this trial. Eleven patients were affected by bilateral tendinopathy. They underwent three ultrasound guided intra-tendinous injections of five millilitres PRP, two weeks apart from each other. Patients were prospectively evaluated initially, then after two, six, and up to mean 48.6 ± 8.1 months of follow-up (minimum evaluation at 36 months). The following evaluation tools were used: Blanzina, VISA-P, EQ-VAS for general health, and Tegner scores. Patients’ overall satisfaction and time to return to sport were also reported.
Good and stable results were documented over time, with the VISA-P score increasing from 44.1 ± 15.6 at baseline to 61.4 ± 22.2 at two months, 76.6 ± 25.4 at six months, and 84.3 ± 21.6 at four years’ follow-up. The same trend was confirmed by the other scores used, and 80 % of the patients were satisfied and returned to previous sports activities. Significantly poorer results were obtained in patients with a longer history of symptoms, and poor results were also observed in bilateral lesions. No correlation between ultrasonographic and clinical findings could be found.
Multiple injections of PRP provided a good clinical outcome for the treatment of chronic recalcitrant patellar tendinopathy with stable results up to medium-term follow-up. Patients affected by bilateral pathology and presenting a long history of pain obtained significantly poorer results.
KeywordsPlatelet rich plasma Patellar tendinopathy Ultrasound guidance Intra tendon injections
A. Montaperto, S. Bassini: Biomechanics and Technology Innovation Laboratory, Rizzoli Orthopedic Institute, Bologna, Italy.
P. M. Fornasari, A. Cenacchi, M. Vaccari: Immunohematology and Transfusion Medicine Service, Rizzoli Orthopedic Institute, Bologna, Italy.
E. Pignotti, K. Smith: Task Force, Rizzoli Orthopedic Institute, Bologna, Italy.
Conflict of interest
The authors declare that they have no conflict of interest.
- 5.Kettunen JA, Kvist M, Alanen E et al (2002) Long term prognosis for jumper’s knee in male athletes. A prospective follow-up study. Am J Sport Med 30(5):689–692Google Scholar
- 21.Bosch G, van Schie HT, de Groot MW, Cadby JA, van de Lest CH, Barneveld A, van Weeren PR (2010) Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: A placebo-controlled experimental study. J Orthop Res 28(2):211–217PubMedGoogle Scholar
- 26.de Jonge S, de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL (2011) One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med 39(8):1623–1629PubMedCrossRefGoogle Scholar
- 32.van Ark M, van den Akker-Scheek I, Meijer LT, Zwerver J (2013) An exercise-based physical therapy program for patients with patellar tendinopathy after platelet-rich plasma injection. Phys Ther Sport 14(2):124–130. doi: 10.1016/j.ptsp.2012.05.002
- 33.Gosens T, Den Oudsten BL, Fievez E, van't Spijker P, Fievez A (2012) Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int Orthop 36(9):1941–1946PubMedCrossRefGoogle Scholar